Ophthalmology Drugs  Market Report

Global Ophthalmology Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：168
  • REPORT CODE：GMM857929
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Ophthalmology Drugs market report explains the definition, types, applications, major countries, and major players of the Ophthalmology Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Roche

    • Regeneron

    • Allergan

    • Bayer

    • Mallinckrodt

    • Novartis

    • Shire

    By Type:

    • Lucentis (ranibizumab)

    • Eylea (aflibercept)

    • Avastin (bevacizumab)

    • Restasis (cyclosporine)

    • Alphagan (brimonidine tartrate)

    • Lumigan (bimatoprost)

    • Xalatan (latanoprost

    By End-User:

    • Chorioretinitis

    • Choroiditis

    • Retinitis

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Ophthalmology Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Ophthalmology Drugs Outlook to 2028- Original Forecasts

    • 2.2 Ophthalmology Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Ophthalmology Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Ophthalmology Drugs Market- Recent Developments

    • 6.1 Ophthalmology Drugs Market News and Developments

    • 6.2 Ophthalmology Drugs Market Deals Landscape

    7 Ophthalmology Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Ophthalmology Drugs Key Raw Materials

    • 7.2 Ophthalmology Drugs Price Trend of Key Raw Materials

    • 7.3 Ophthalmology Drugs Key Suppliers of Raw Materials

    • 7.4 Ophthalmology Drugs Market Concentration Rate of Raw Materials

    • 7.5 Ophthalmology Drugs Cost Structure Analysis

      • 7.5.1 Ophthalmology Drugs Raw Materials Analysis

      • 7.5.2 Ophthalmology Drugs Labor Cost Analysis

      • 7.5.3 Ophthalmology Drugs Manufacturing Expenses Analysis

    8 Global Ophthalmology Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Ophthalmology Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Ophthalmology Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Ophthalmology Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Ophthalmology Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lucentis (ranibizumab) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Eylea (aflibercept) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Avastin (bevacizumab) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Restasis (cyclosporine) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Alphagan (brimonidine tartrate) Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Lumigan (bimatoprost) Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Xalatan (latanoprost Consumption and Growth Rate (2017-2022)

    • 9.2 Global Ophthalmology Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Chorioretinitis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Choroiditis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retinitis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Ophthalmology Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Ophthalmology Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Ophthalmology Drugs Consumption (2017-2022)

      • 10.2.2 Canada Ophthalmology Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Ophthalmology Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.2 UK Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.3 Spain Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.5 France Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.6 Italy Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.8 Finland Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.9 Norway Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.11 Poland Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.12 Russia Ophthalmology Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Ophthalmology Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.2 Japan Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.3 India Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Ophthalmology Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Ophthalmology Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Ophthalmology Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Ophthalmology Drugs Consumption (2017-2022)

      • 10.5.3 Chile Ophthalmology Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Ophthalmology Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Ophthalmology Drugs Consumption (2017-2022)

      • 10.5.6 Peru Ophthalmology Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Ophthalmology Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Ophthalmology Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Ophthalmology Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Ophthalmology Drugs Consumption (2017-2022)

      • 10.6.3 Oman Ophthalmology Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Ophthalmology Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Ophthalmology Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Ophthalmology Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Ophthalmology Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Ophthalmology Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Ophthalmology Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Ophthalmology Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Ophthalmology Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Ophthalmology Drugs Consumption (2017-2022)

    11 Global Ophthalmology Drugs Competitive Analysis

    • 11.1 Roche

      • 11.1.1 Roche Company Details

      • 11.1.2 Roche Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Roche Ophthalmology Drugs Main Business and Markets Served

      • 11.1.4 Roche Ophthalmology Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Regeneron

      • 11.2.1 Regeneron Company Details

      • 11.2.2 Regeneron Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Regeneron Ophthalmology Drugs Main Business and Markets Served

      • 11.2.4 Regeneron Ophthalmology Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Allergan

      • 11.3.1 Allergan Company Details

      • 11.3.2 Allergan Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Allergan Ophthalmology Drugs Main Business and Markets Served

      • 11.3.4 Allergan Ophthalmology Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Bayer

      • 11.4.1 Bayer Company Details

      • 11.4.2 Bayer Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Bayer Ophthalmology Drugs Main Business and Markets Served

      • 11.4.4 Bayer Ophthalmology Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Mallinckrodt

      • 11.5.1 Mallinckrodt Company Details

      • 11.5.2 Mallinckrodt Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Mallinckrodt Ophthalmology Drugs Main Business and Markets Served

      • 11.5.4 Mallinckrodt Ophthalmology Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis

      • 11.6.1 Novartis Company Details

      • 11.6.2 Novartis Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis Ophthalmology Drugs Main Business and Markets Served

      • 11.6.4 Novartis Ophthalmology Drugs Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Shire

      • 11.7.1 Shire Company Details

      • 11.7.2 Shire Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Shire Ophthalmology Drugs Main Business and Markets Served

      • 11.7.4 Shire Ophthalmology Drugs Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Ophthalmology Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Ophthalmology Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Lucentis (ranibizumab) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Eylea (aflibercept) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Avastin (bevacizumab) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Restasis (cyclosporine) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Alphagan (brimonidine tartrate) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Lumigan (bimatoprost) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Xalatan (latanoprost Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Ophthalmology Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Chorioretinitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Choroiditis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Retinitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Ophthalmology Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Ophthalmology Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Ophthalmology Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Ophthalmology Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Ophthalmology Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Ophthalmology Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Ophthalmology Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Ophthalmology Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Ophthalmology Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Ophthalmology Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Ophthalmology Drugs

    • Figure of Ophthalmology Drugs Picture

    • Table Global Ophthalmology Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Ophthalmology Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Lucentis (ranibizumab) Consumption and Growth Rate (2017-2022)

    • Figure Global Eylea (aflibercept) Consumption and Growth Rate (2017-2022)

    • Figure Global Avastin (bevacizumab) Consumption and Growth Rate (2017-2022)

    • Figure Global Restasis (cyclosporine) Consumption and Growth Rate (2017-2022)

    • Figure Global Alphagan (brimonidine tartrate) Consumption and Growth Rate (2017-2022)

    • Figure Global Lumigan (bimatoprost) Consumption and Growth Rate (2017-2022)

    • Figure Global Xalatan (latanoprost Consumption and Growth Rate (2017-2022)

    • Figure Global Chorioretinitis Consumption and Growth Rate (2017-2022)

    • Figure Global Choroiditis Consumption and Growth Rate (2017-2022)

    • Figure Global Retinitis Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmology Drugs Consumption by Country (2017-2022)

    • Table North America Ophthalmology Drugs Consumption by Country (2017-2022)

    • Figure United States Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Ophthalmology Drugs Consumption by Country (2017-2022)

    • Figure Germany Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Ophthalmology Drugs Consumption by Country (2017-2022)

    • Figure China Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Ophthalmology Drugs Consumption by Country (2017-2022)

    • Figure Brazil Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Ophthalmology Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Ophthalmology Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Ophthalmology Drugs Consumption by Country (2017-2022)

    • Figure Australia Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Ophthalmology Drugs Consumption and Growth Rate (2017-2022)

    • Table Roche Company Details

    • Table Roche Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Ophthalmology Drugs Main Business and Markets Served

    • Table Roche Ophthalmology Drugs Product Portfolio

    • Table Regeneron Company Details

    • Table Regeneron Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Ophthalmology Drugs Main Business and Markets Served

    • Table Regeneron Ophthalmology Drugs Product Portfolio

    • Table Allergan Company Details

    • Table Allergan Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Ophthalmology Drugs Main Business and Markets Served

    • Table Allergan Ophthalmology Drugs Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Ophthalmology Drugs Main Business and Markets Served

    • Table Bayer Ophthalmology Drugs Product Portfolio

    • Table Mallinckrodt Company Details

    • Table Mallinckrodt Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Ophthalmology Drugs Main Business and Markets Served

    • Table Mallinckrodt Ophthalmology Drugs Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Ophthalmology Drugs Main Business and Markets Served

    • Table Novartis Ophthalmology Drugs Product Portfolio

    • Table Shire Company Details

    • Table Shire Ophthalmology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Ophthalmology Drugs Main Business and Markets Served

    • Table Shire Ophthalmology Drugs Product Portfolio

    • Figure Global Lucentis (ranibizumab) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Eylea (aflibercept) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Avastin (bevacizumab) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Restasis (cyclosporine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alphagan (brimonidine tartrate) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lumigan (bimatoprost) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Xalatan (latanoprost Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chorioretinitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Choroiditis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retinitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmology Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Ophthalmology Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Ophthalmology Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Ophthalmology Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Ophthalmology Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Ophthalmology Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Ophthalmology Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Ophthalmology Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Ophthalmology Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US